Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.54 |
| ▸ | MMP1 | P03956 | 1/20 | 0.54 |
| ▸ | FOS | P01100 | 1/20 | 0.53 |
| ▸ | TTR | P02766 | 1/20 | 0.53 |
| ▸ | JUN | P05412 | 1/20 | 0.53 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.53 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.53 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.51 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.51 |
| ▸ | AR | P10275 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Vanillyl Alcohol SCHEMBL117402 | 0.91 | CYP3A4 (0.52) | TAAR1TSHRMAPK1CYP3A4MMP1 | |
| Vanillyl Alcohol SCHEMBL14358230 | 0.89 | CYP1A2 (0.54) | CYP3A4ALDH1A1ALOX15CYP1A2CYP2C8 | |
| Vanillyl Alcohol SCHEMBL2238547 | 0.88 | TAAR1 (0.62) | TAAR1TSHRMAPK1CYP3A4MMP1 | |
| Vanillyl Alcohol SCHEMBL117979 | 0.88 | CYP1A2 (0.56) | CYP3A4ALDH1A1ALOX15CYP1A2CYP2C8 | |
| Vanillyl Alcohol SCHEMBL62348 | 0.88 | TAAR1 (0.67) | TAAR1TSHRMAPK1CYP3A4MMP1 | |
| Vanillyl Alcohol SCHEMBL29408335 | 0.88 | TAAR1 (0.67) | TAAR1TSHRMAPK1CYP3A4MMP1 | |
| Vanillyl Alcohol SCHEMBL27774687 | 0.88 | TAAR1 (0.67) | TAAR1TSHRMAPK1CYP3A4MMP1 | |
| Vanillyl Alcohol SCHEMBL3386819 | 0.87 | CYP1A2 (0.55) | CYP3A4ALDH1A1ALOX15CYP1A2CYP2C8 | |
| Vanillyl Alcohol SCHEMBL15272606 | 0.87 | CYP1A2 (0.55) | CYP3A4ALDH1A1ALOX15CYP1A2CYP2C8 | |
| Vanillyl Alcohol SCHEMBL579759 | 0.87 | TAAR1 (0.57) | TAAR1TSHRMAPK1CYP3A4MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 984 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113576987-A | Massage gel applied to wave instrument and preparation method thereof | 广州丽亦健美容美体设备有限公司 | 2021-11-02 | — | — | CN | claimed |
| CN-113389055-A | Cool or heat-sensitive microcapsule, nonwoven fabric and absorbent article | 上海护理佳实业有限公司 | 2021-09-14 | — | — | CN | claimed |
| US-20210212983-A1 | ORAL CANNABINOID DELIVERY FORMULATIONS WITH MOUTHFEEL EXPERIENCE ENHANCERS | CHICAGO ATLANTIC ADMIN, LLC | 2021-07-15 | — | — | US | claimed |
| CN-112513162-A | Novel compositions for bittering agents | UPL有限公司 | 2021-03-16 | — | — | CN | claimed |
| CN-104887581-B | A kind of oral care composition and preparation method thereof | 云南天美天康生物科技有限公司 | 2018-02-23 | — | — | CN | claimed |
| EP-2742983-B1 | Method for isolating fragrance and flavour compounds | SYMRISE AG (DE) | 2017-08-23 | — | — | EP | claimed |
| EP-1924148-B1 | CONFECTIONERY COMPOSITION INCLUDING AN ELASTOMERIC COMPONENT, A COOKED SACCHARIDE COMPONENT, AND A SENSATE | INTERCONTINENTAL GREAT BRANDS LLC (US) | 2016-07-20 | — | — | EP | claimed |
| US-20160198747-A1 | 1H-PYRROLE-DICARBONYL-DERIVATIVES AND THEIR USE AS FLAVORING AGENTS | IMAX DISCOVERY GMBH (DE) | 2016-07-14 | — | — | US | claimed |
| EP-3041370-A1 | 1H-PYRROLE-2,4-DICARBONYL-DERIVATIVES AND THEIR USE AS FLAVORING AGENTS | IMAX Discovery GmbH (DE) | 2016-07-13 | — | — | EP | claimed |
| CN-105473002-A | 1H-PYRROLE-2,4-DICARBONYL-DERIVATIVES AND THEIR USE AS FLAVORING AGENTS | FRESENIUS KABI DE GMBH | 2016-04-06 | — | — | CN | claimed |
| EP-0977554-B1 | CONFECTIONERY COMPOSITIONS | PROCTER & GAMBLE (US) | 2004-06-16 | — | — | EP | claimed |
| EP-0977553-B1 | THROAT SOOTHING COMPOSITIONS | PROCTER & GAMBLE (US) | 2003-09-10 | — | — | EP | claimed |
| US-6432441-B1 | ENCAPSULATION OF ANALGESICS, EXPECTORANTS OR ANTITUSSIVE AGENTS WITHIN PHOSPHATIDES TO PROLONG DRUG DELIVERY | THE PROCTER & GAMBLE COMPANY | 2002-08-13 | — | — | US | claimed |
| US-6306429-B1 | THROAT DROPS SUITABLE FOR RELIEF OF COUGH AND COLD SYMPTOMS | THE PROCTER & GAMBLE COMPANY | 2001-10-23 | — | — | US | claimed |
| EP-0977554-A1 | CONFECTIONERY COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2000-02-09 | — | — | EP | claimed |
| EP-0977553-A1 | THROAT SOOTHING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2000-02-09 | — | — | EP | claimed |
| WO-1998047483-A1 | CONFECTIONERY COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-10-29 | — | — | WO | claimed |
| WO-1998047482-A1 | THROAT SOOTHING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-10-29 | — | — | WO | claimed |
| EP-0837862-A1 | WARMING COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-29 | — | — | EP | claimed |
| WO-1997002273-A1 | WARMING COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210212983-A1 | ORAL CANNABINOID DELIVERY FORMULATIONS WITH MOUTHFEEL EXPERIENCE ENHANCERS | CNR2, CNR1, CPNE4 | TAAR1 1538/4885TSHR 2158/4885MAPK1 4230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.